Login / Signup

Are all antidepressants the same? The consumer has a point.

Sebastian CaminoSergio A StrejilevichAntonella GodoyJose SmithAlejandro Szmulewicz
Published in: Psychological medicine (2022)
This research points out that the subjective experience of patients under treatment should be taken into consideration when selecting an AD as differences between agents were evident. In contrast to the more frequent treatment decisions, users might prefer receiving a non-serotoninergic agent over a serotonergic one due to their lower propensity to produce emotional blunting.
Keyphrases
  • end stage renal disease
  • magnetic resonance
  • chronic kidney disease
  • ejection fraction
  • healthcare
  • computed tomography
  • depressive symptoms
  • patient reported outcomes